<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Anaesth</journal-id><journal-id journal-id-type="publisher-id">IJA</journal-id><journal-title-group><journal-title>Indian Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">0019-5049</issn><issn pub-type="epub">0976-2817</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20882174</article-id><article-id pub-id-type="pmc">2943701</article-id><article-id pub-id-type="publisher-id">IJA-54-318</article-id><article-id pub-id-type="doi">10.4103/0019-5049.68375</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Investigation</subject></subj-group></article-categories><title-group><article-title>Remifentanil infusion as a modality for opioid-based anaesthesia in paediatric practice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Abdel Hamid</surname><given-names>Ahmed Mostafa</given-names></name><xref ref-type="aff" rid="AF0001"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Abo Shady</surname><given-names>Ashraf Fawzy</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Abdel Azeem</surname><given-names>Ehab S</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib></contrib-group><aff id="AF0001">Department of Anaesthesia and ICU, Benha Faculty of Medicine, Benha University, Egypt</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Ahmed Mostafa Abdel Hamid, 20 EzzEldin Omar St. Elharam, Giza, Egypt. E-mail: <email xlink:href="bashaahmad@yahoo.com">bashaahmad@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2010</year></pub-date><volume>54</volume><issue>4</issue><fpage>318</fpage><lpage>323</lpage><permissions><copyright-statement>&#x000a9; Indian Journal of Anaesthesia</copyright-statement><copyright-year>2010</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>This study was designed to compare the intra-operative and post-operative analgesic requirements and side effects of using fentanyl infusion versus remifentanil infusion during short-duration surgical procedures in children. The study comprised of 40 children randomly allocated into two equal groups: fentanyl (F-group) or remifentanil (R-group). Both were administered a continuous intravenous (i.v.) infusion. Anaesthetic recovery was assessed using the Brussels sedation scale every 5 min from the time of entry till discharge from recovery room. Post-operative analgesia was assessed throughout the first three post-operative (PO) hours using observational pain&#x02013;discomfort scale (OPS) and adverse events were recorded. Haemodynamic variables showed a non-significant difference between both the groups. Patients who received remifentanil showed significantly shorter time to spontaneous respiration, eye opening, extubation and verbalization compared to those who received fentanyl. Discharge time was significantly shorter in R-group, and 18 patients fulfilled criteria for recovery-room discharge at &#x02264;25 min with a significant difference in favour of remifentanil. Fentanyl provided significantly better PO analgesia than remifentanil and children in F-group showed a significantly lower mean cumulative OPS record than those in R-group; however, the number of patients requiring rescue analgesia did not show a significant difference between both the groups. Two cases in F-group and one in R-group had bradycardia, one case in R-group had mild hypotension and PO vomiting had occurred in three patients in the F-group and two patients in the R-group. In conclusion, remifentanil is appropriate for opioid-based anaesthesia for paediatric patients as it provides haemodynamic stability and rapid recovery with minimal post-operative side effects.</p></abstract><kwd-group><kwd>Opioid based</kwd><kwd>paediatric</kwd><kwd>remifentanil</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Remifentanil is a &#x000b5;-opioid receptor agonist with an analgesic potency similar to that of fentanyl.[<xref ref-type="bibr" rid="CIT1">1</xref>] Remifentanil is an analogue of fentanyl (4-piperi-dyl anilide) with a methyl-ester group that allows the molecule to be hydrolysed by non-specific tissue and plasma esterases.[<xref ref-type="bibr" rid="CIT2">2</xref>] Rapid biotransformation to minimally active metabolites should be associated with a short duration of action with no accumulation of effect on repeated dosing or with continuous infusion.[<xref ref-type="bibr" rid="CIT3">3</xref>] These pharmacokinetic properties could explain the rapid onset and short duration of action of remifentanil.[<xref ref-type="bibr" rid="CIT4">4</xref>]</p><p>Remifentanil has a rapid onset, rapid offset, small volume of distribution, rapid clearance, and a short elimination half-life,[<xref ref-type="bibr" rid="CIT5">5</xref>] so, it may be a useful anaesthetic for paediatric outpatient surgery.[<xref ref-type="bibr" rid="CIT6">6</xref>]</p><p>Opioids are often used in combination with propofol. The combination of these two drugs may be particularly useful for procedures of short duration.[<xref ref-type="bibr" rid="CIT7">7</xref>]</p><p>Combining a hypnotic and an analgesic to produce sedation, analgesia and surgical immobility is more common than administration of a volatile anaesthetic alone, and response surface analyses demonstrate a synergistic interaction between remifentanil and sevoflurane for sedation and all analgesic endpoints.[<xref ref-type="bibr" rid="CIT8">8</xref>]</p><p>This study was designed to compare the outcome of using fentanyl infusion versus remifentanil infusion in conjunction with a volatile anaesthetic during short-duration surgical procedures in children.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>This study comprised 40 children, aged 3.5&#x02013;8 years, assigned to undergo lower abdominal hernia repair procedures under general anaesthesia. After obtaining informed parental consent, children were randomly allocated into two equal groups (<italic>n</italic>=20 patients) according to opioid to be used; either fentanyl (F-group) or remifentanil (R-group). Patients with contraindication to the use of either of the study drugs or inhalational anaesthesia and patients with respiratory pathology were excluded from the study. Single blinding technique was used. Standard monitoring included electrocardiogram (ECG), pulse oximetry (SpO<sub>2</sub>), non-invasive blood pressure (NIBP) and end tidal carbon dioxide (ETCO<sub>2</sub>). All patients were premedicated using oral midazolam 0.15 mg/kg, and anaesthesia was induced with sevoflurane 6% in oxygen 6 L/min via facemask. After an IV cannula was inserted, atracurium 0.3&#x02013;0.5 mg/kg was administered to facilitate tracheal intubation and provide muscle relaxation. Controlled ventilation via closed circuit was used. The ventilation parameters are oxygen 100%, tidal volume 7&#x02013;10 mL/kg, respiratory rate 16&#x02013;20/min and I:E (Inspiratory to Expiratory ratio) ratio 1:2. Throughout the operative procedure, sevoflurane concentration was 3% and ETCO<sub>2</sub> was maintained at 35&#x02013;45 mmHg. Before surgical manipulation, ondansetron (100 &#x000b5;g/kg) and dexamethasone (0.25&#x02013;0.5 mg/kg) were administered i.v. to prevent post-operative (PO) nausea and vomiting (PONV)</p><p>Fentanyl was initially given as a continuous i.v. infusion at 5 &#x000b5;g/kg/min. After endotracheal intubation, fentanyl infusion was reduced to 2.5 &#x000b5;g/kg/min. Remifentanil was initially given as a continuous i.v. infusion at 0.5 &#x000b5;g/kg/min and after endotracheal intubation, remifentanil infusion was reduced to 0.25 &#x000b5;g/kg/min. The infusion rates were later adjusted as required to treat light anaesthesia responses classified by autonomic responses (lacrimation, sweating, increase of blood pressure or heart rate), or anticipated changes in magnitude on surgical stimulation.</p><p>Light anaesthesia responses were recorded at the time of induction, one and five minutes after intubation, at time of skin incision and closure, and five minutes after transfer to the recovery room. Incidence of adverse events were monitored throughout the study period included: 1) hypotension (&#x02265;20% decrease compared with baseline blood pressure), 2) bradycardia defined as heart rates &#x0003c;80 beats per minute for at least 1 min. Hypotension was treated by infusion of lactated Ringer&#x02019;s solution, and for bradycardia atropine sulphate (0.01 mg/kg) was administered.</p><p>Ten minutes before anticipated end of surgery, the study drugs infusion rate was decreased to 0.5 &#x000b5;g/kg/min in F-group and to 0.05 &#x000b5;g/kg/min in the R-group. At the end of surgery, neuromuscular block was reversed with neostigmine and atropine and the infusion of drugs was stopped. Anaesthetic recovery was assessed using the Brussels sedation scale, graded as unarousable (level 1), responds to painful not auditory stimuli (level 2), responds to auditory stimuli (level 3), awake, calm, able to follow commands and had motor function unchanged from their pre-operative evaluation (level 4) and agitated (level 5). Patients were considered to have normal recovery on approaching level 4 on Brussels sedation scale. Recovery score was recorded every five minutes from the time of entry till discharge from recovery room. The recovery-room discharge time was defined as the time elapsed from cessation of the anaesthesia till reaching level 4 on Brussels sedation scale and before being agitated and required analgesia.</p><p>Post-operative analgesia was assessed throughout the first three PO hours using observational pain&#x02013;discomfort scale (OPS), which assessed behavioural objective parameters, namely crying, facial expression, position of tarso, position of the legs, and motor restlessness. Each variable was scored on a three-point scale (1 = none, 2 = moderate, and 3 = severe) to give a cumulative score of 5&#x02013;15 to estimate the quality of analgesia (5 = excellent, 15 = ineffective). Adverse events like hypotension, bradycardia, hypoxia, and dysarrythymias and the occurrence of PO vomiting were recorded.</p><p>Statistical analysis was conducted using the SPSS (Version 10, 2002) for Windows statistical package, using <italic>t</italic>-test for independent sample and Chi-square test.</p><p><italic>P</italic> value &#x0003c;0.05 was considered statistically significant with the power of the study being 90%.</p></sec><sec id="sec1-3"><title>RESULTS</title><p>The study included 40 patients with mean age of 5.4 &#x000b1; 1.4; range: 3.5&#x02013;8 years and mean weight of 18.9 &#x000b1; 2.8; range: 15&#x02013;24 kg. There were 35 patients ASA grade I and 5 patients ASA grade II. All patients completed the study with a non-significant (<italic>P</italic>&#x0003e;0.05) difference between both groups in the terms of age, body weight, gender distribution, and ASA classification. The duration of surgery and anaesthesia was 55.2 &#x000b1; 11.4 and 64.6 &#x000b1; 13.3 min, respectively. Mean dose of ondansetron and dexamethasone used was 2 &#x000b1; 0.3 and 4.9 &#x000b1; 0.8 mg, respectively. Also, both groups were comparable with a non-significant difference as regards to duration of surgery and anaesthesia and dose usage of ondansetron and dexamethasone [<xref ref-type="table" rid="T0001">Table 1</xref>].</p><table-wrap id="T0001" position="float"><label>Table 1</label><caption><p>Patient demographics and operative data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Data</th><th align="center" rowspan="1" colspan="1">F-group (n=20)</th><th align="center" rowspan="1" colspan="1">R-group (n=20)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">5.7&#x000b1;1.3</td><td align="center" rowspan="1" colspan="1">5.3&#x000b1;1.5</td><td align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex; M:F</td><td align="center" rowspan="1" colspan="1">11:9</td><td align="center" rowspan="1" colspan="1">13:7</td><td align="center" rowspan="1" colspan="1">0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (Kg)</td><td align="center" rowspan="1" colspan="1">19.1&#x000b1;2.7</td><td align="center" rowspan="1" colspan="1">18.6&#x000b1;3</td><td align="center" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">ASA; I:II</td><td align="center" rowspan="1" colspan="1">17:3</td><td align="center" rowspan="1" colspan="1">18:2</td><td align="center" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of surgery (min)</td><td align="center" rowspan="1" colspan="1">54.9&#x000b1;12.4</td><td align="center" rowspan="1" colspan="1">57.2&#x000b1;10.7</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of anaesthesia (min)</td><td align="center" rowspan="1" colspan="1">64.2&#x000b1;14.5</td><td align="center" rowspan="1" colspan="1">67&#x000b1;12.5</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Dose of ondansteron (mg)</td><td align="center" rowspan="1" colspan="1">2&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">1.98&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Dose of dexamethasone (mg)</td><td align="center" rowspan="1" colspan="1">4.9&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">5&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">0.7</td></tr></tbody></table></table-wrap><table-wrap id="T0002" position="float"><label>Table 2</label><caption><p>Haemodynamic responses detected in studied groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Data</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">F-group (n=20)</th><th align="center" rowspan="1" colspan="1">R-group (n=20)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SBP (mmHg)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">78&#x000b1;4.6</td><td align="center" rowspan="1" colspan="1">78.7&#x000b1;4</td><td align="center" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Induction</td><td align="center" rowspan="1" colspan="1">74.8&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">73.4&#x000b1;4.3</td><td align="center" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1-min after intubation</td><td align="center" rowspan="1" colspan="1">82.2&#x000b1;6.9</td><td align="center" rowspan="1" colspan="1">81.5&#x000b1;6.2</td><td align="center" rowspan="1" colspan="1">0.7</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5-min after intubation</td><td align="center" rowspan="1" colspan="1">78.7&#x000b1;5.2</td><td align="center" rowspan="1" colspan="1">77.3&#x000b1;4.6</td><td align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Skin incision</td><td align="center" rowspan="1" colspan="1">67.3&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">68&#x000b1;5.2</td><td align="center" rowspan="1" colspan="1">0.7</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Skin closure</td><td align="center" rowspan="1" colspan="1">76.3&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">75.3&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">At discharge from recovery room</td><td align="center" rowspan="1" colspan="1">82.4&#x000b1;7.5</td><td align="center" rowspan="1" colspan="1">80.7&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (mmHg)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">52.3&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">51.3&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Induction</td><td align="center" rowspan="1" colspan="1">50&#x000b1;2.4</td><td align="center" rowspan="1" colspan="1">49.3&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1-min after intubation</td><td align="center" rowspan="1" colspan="1">51.3&#x000b1;4</td><td align="center" rowspan="1" colspan="1">54.3&#x000b1;6</td><td align="center" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5-min after intubation</td><td align="center" rowspan="1" colspan="1">51.9&#x000b1;2.4</td><td align="center" rowspan="1" colspan="1">53.8&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">0.2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Skin incision</td><td align="center" rowspan="1" colspan="1">48&#x000b1;3.3</td><td align="center" rowspan="1" colspan="1">47&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Skin closure</td><td align="center" rowspan="1" colspan="1">49.3&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">50&#x000b1;1.5</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">At discharge from recovery room</td><td align="center" rowspan="1" colspan="1">48.7&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">50.7&#x000b1;1.8</td><td align="center" rowspan="1" colspan="1">0.02<xref ref-type="table-fn" rid="T000F1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HR (bpm)</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="center" rowspan="1" colspan="1">131.9&#x000b1;5</td><td align="center" rowspan="1" colspan="1">128.1&#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">0.009<xref ref-type="table-fn" rid="T000F1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Induction</td><td align="center" rowspan="1" colspan="1">133.1&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">132.3&#x000b1;6.9</td><td align="center" rowspan="1" colspan="1">0.7</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1-min after intubation</td><td align="center" rowspan="1" colspan="1">137.6&#x000b1;5.9</td><td align="center" rowspan="1" colspan="1">136.7&#x000b1;5.9</td><td align="center" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5-min after intubation</td><td align="center" rowspan="1" colspan="1">134.9&#x000b1;8.1</td><td align="center" rowspan="1" colspan="1">133.3&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Skin incision</td><td align="center" rowspan="1" colspan="1">131&#x000b1;7.6</td><td align="center" rowspan="1" colspan="1">126.1&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">0.01<xref ref-type="table-fn" rid="T000F1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Skin closure</td><td align="center" rowspan="1" colspan="1">131.7&#x000b1;7.1</td><td align="center" rowspan="1" colspan="1">129.3&#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">0.2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">At discharge from recovery room</td><td align="center" rowspan="1" colspan="1">133.2&#x000b1;5</td><td align="center" rowspan="1" colspan="1">130&#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">0.02<xref ref-type="table-fn" rid="T000F1">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="T000F1"><label>*</label><p>means significant</p></fn></table-wrap-foot></table-wrap><p>Haemodynamic variables recorded throughout the study period showed a non-significant difference (<italic>P</italic>&#x0003e;0.05) in response to the use of either remifentanil or fentanyl despite the responses detected at intubation, skin closure, and light anaesthesia being more frequent in fentanyl group [<xref ref-type="table" rid="T0002">Table 2</xref>]. Patients who received remifentanil showed superior emergence of anaesthesia compared to those who received fentanyl as shown by significantly shorter time (<italic>P</italic>&#x0003c;0.05) to respire spontaneously, to eye opening, to extubation and to verbalization [<xref ref-type="table" rid="T0003">Table 3</xref>, <xref ref-type="fig" rid="F0001">Figure 1</xref>].</p><fig id="F0001" position="float"><label>Figure 1</label><caption><p>Mean (&#x000b1;SD) emergence time after discontinuation of anaesthetic</p></caption><graphic xlink:href="IJA-54-318-g001"/></fig><table-wrap id="T0003" position="float"><label>Table 3</label><caption><p>Mean (&#x000b1;SD) emergence time after discontinuation of anaesthetic</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Time (min) to</th><th align="center" rowspan="1" colspan="1">F-group (n=20)</th><th align="center" rowspan="1" colspan="1">R-group (n=20)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Spontaneous respiration</td><td align="center" rowspan="1" colspan="1">3.4&#x000b1;1.92</td><td align="center" rowspan="1" colspan="1">1.8&#x000b1;0.82</td><td align="center" rowspan="1" colspan="1">0.004<xref ref-type="table-fn" rid="T000F2">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Eye opening</td><td align="center" rowspan="1" colspan="1">4.2&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">2.63&#x000b1;0.44</td><td align="center" rowspan="1" colspan="1">0.014<xref ref-type="table-fn" rid="T000F2">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Extubation</td><td align="center" rowspan="1" colspan="1">5.87&#x000b1;1.81</td><td align="center" rowspan="1" colspan="1">3.57&#x000b1;0.53</td><td align="center" rowspan="1" colspan="1">0.012<xref ref-type="table-fn" rid="T000F2">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Verbalization</td><td align="center" rowspan="1" colspan="1">8.4&#x000b1;1.64</td><td align="center" rowspan="1" colspan="1">4.47&#x000b1;0.67</td><td align="center" rowspan="1" colspan="1">0.010<xref ref-type="table-fn" rid="T000F2">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="T000F2"><label>*</label><p>means significant</p></fn></table-wrap-foot></table-wrap><p>Time to qualify for recovery-room discharge was significantly shorter (Z = 2.101, <italic>P</italic> = 0.036) in patients who received remifentanil, (20.5 &#x000b1; 5 min) compared to those who received fentanyl (24.9 &#x000b1; 5.5 min) [<xref ref-type="fig" rid="F0002">Figure 2</xref>]. Furthermore, 18 patients (90%) fulfilled criteria for recovery-room discharge at &#x02264;25 min in case of remifentanil group, while 15 patients (75%) who received fentanyl were ready to discharge at &#x02264;25 min, with a significant difference (&#x003c7;<sup>2</sup> = 5.733, <italic>P</italic> = 0.01) in favour of remifentanil [<xref ref-type="fig" rid="F0003">Figure 3</xref>].</p><fig id="F0002" position="float"><label>Figure 2</label><caption><p>Mean time (&#x000b1;SD) till discharge from the recovery room estimated in both groups</p></caption><graphic xlink:href="IJA-54-318-g002"/></fig><fig id="F0003" position="float"><label>Figure 3</label><caption><p>Number of patients ready for discharge from the recovery room at 25 minutes in both groups</p></caption><graphic xlink:href="IJA-54-318-g003"/></fig><p>Fentanyl provided significantly better PO analgesia than remifentanil; children administered fentanyl showed a mean cumulative OPS record throughout the first three PO hours, which was significantly (Z = 2.201, <italic>P</italic> = 0.028) lower than that recorded for children who received remifentanil (6.67 &#x000b1; 0.4 vs. 6.9 &#x000b1; 0.5, respectively) [<xref ref-type="fig" rid="F0004">Figure 4</xref>]. However, number of patients required rescue analgesia despite increase in both groups did not show a significant difference (&#x003c7;<sup>2</sup> = 0.094, <italic>P</italic> &#x0003e; 0.05) between children who received fentanyl (13 patients) or remifentanil (16 patients) [<xref ref-type="fig" rid="F0005">Figure 5</xref>].</p><fig id="F0004" position="float"><label>Figure 4</label><caption><p>Mean (&#x000b1;SD) OPS score determined in both groups throughout the first 3 postoperative hours</p></caption><graphic xlink:href="IJA-54-318-g004"/></fig><fig id="F0005" position="float"><label>Figure 5</label><caption><p>Patients&#x02019; distribution according to request of postoperative analgesia</p></caption><graphic xlink:href="IJA-54-318-g005"/></fig><p>No cases of dysrhythmia were detected; however, two cases in fentanyl group, while one in remifentanil group had bradycardia that required intravenous injection of atropine sulphate. Only one case of mild hypotension was detected in remifentanil and required fluid therapy for adjustment of blood pressure. Hypoxia (decreased O<sub>2</sub> saturation less than 90%) was encountered in only one case in fentanyl group. Post-operative vomiting had occurred in five patients, three in fentanyl group and two patients in remifentanil group [<xref ref-type="table" rid="T0004">Table 4</xref>]. Despite the apparent increased incidence of adverse events in fentanyl group, the difference did not reach the significance level (&#x003c7;<sup>2</sup> =0.012, <italic>P</italic>&#x0003e;0.05).</p><table-wrap id="T0004" position="float"><label>Table 4</label><caption><p>Adverse events occurring intra- and post-operatively</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Data</th><th align="center" rowspan="1" colspan="1">F-group (n=20)</th><th align="center" rowspan="1" colspan="1">R-group (n=20)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Hypotension</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1 (5)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Bradycardia</td><td align="center" rowspan="1" colspan="1">2 (10)</td><td align="center" rowspan="1" colspan="1">1 (5)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Hypoxia</td><td align="center" rowspan="1" colspan="1">1 (5)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Dysrhythmia</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Vomiting</td><td align="center" rowspan="1" colspan="1">3 (15)</td><td align="center" rowspan="1" colspan="1">2 (10)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">6 (30)</td><td align="center" rowspan="1" colspan="1">4 (20)</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Figures in parentheses are in percentages</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>The combination of newer anaesthetic agents, such as desflurane, remifentanil, sevoflurane and propofol allow us to provide anaesthetic care in an effective and efficient way.[<xref ref-type="bibr" rid="CIT9">9</xref>] When remifentanil infusion 0.3 mg/kg/min is used in patients scheduled for paediatric urologic surgeries, the haemodynamic variables remained stable within their age limits.[<xref ref-type="bibr" rid="CIT10">10</xref>]</p><p>Maximum cardiovascular depression can be seen after the first dose of remifentanil and it could be prevented through premedication with glycopyrrolate,[<xref ref-type="bibr" rid="CIT11">11</xref>] and the haemodynamic response to remifentanil appears to be similar to that of other anilidopiperidines.[<xref ref-type="bibr" rid="CIT12">12</xref>] This hypotension and bradycardia associated with remifentanil infusion can be treated with a vasopressor, atropine or a combination of both drugs.[<xref ref-type="bibr" rid="CIT13">13</xref>]</p><p>Remifentanil provides haemodynamically more stable anaesthesia compared with ketamine or placebo in paediatric day-care anaesthesia.[<xref ref-type="bibr" rid="CIT14">14</xref>] The mean arterial pressure and heart rate may be decreased in patients receiving remifentanil or propofol.[<xref ref-type="bibr" rid="CIT15">15</xref>]</p><p>Patients who received remifentanil showed superior emergence from anaesthesia compared to those who received fentanyl, with significantly shorter time for onset of breathing, eye opening, extubation, and verbalization.[<xref ref-type="bibr" rid="CIT16">16</xref>&#x02013;<xref ref-type="bibr" rid="CIT18">18</xref>] The time to follow verbal commands and tracheal extubation were more rapid after remifentanil. When compared with the recovery profile of fentanyl, it is reported that remifentanil group shows early recovery.[<xref ref-type="bibr" rid="CIT19">19</xref>]</p><p>Cicek[<xref ref-type="bibr" rid="CIT20">20</xref>] compared the effects of propofol&#x02013;alfentanil or propofol&#x02013;remifentanil anaesthesia on haemodynamics and recovery characteristics during percutaneous nephrolithotripsy and found that with alfentanil, mean arterial pressure was higher at the first minute in the prone position, and during skin incision and lithotripsy, and heart rate was higher during skin incision and lithotripsy when compared with remifentanil group. The time of recovery for spontaneous ventilation, extubation, and eye opening were significantly shorter with remifentanil than with alfentanil.</p><p>In the present study, the time to qualify for recovery-room discharge was significantly shorter in R-group as compared to F-group. Tsui[<xref ref-type="bibr" rid="CIT4">4</xref>] observed the recovery and discharge times of combined remifentanil and propofol total intravenous anaesthesia in spontaneously breathing children and he found the mean recovery and discharge times were 8.9 and 28.2 min, respectively, and one patient experienced post-procedure nausea and vomiting in his study. The recovery characteristics of two anaesthetic techniques in children undergoing short painful oncology procedures, the discharge readiness from the recovery ward was achieved at 19 min after propofol with remifentanil when compared with the combination of propofol, sevoflurane, and nitrous oxide.[<xref ref-type="bibr" rid="CIT21">21</xref>]</p><p>Fentanyl provided better PO analgesia during the early PO period than remifentanil; however, there is no significant difference in the number of patients requiring rescue analgesia among two groups. The lower pain scores in the remifentanil anaesthetised patients observed in current study can be attributed to the post-anaesthetic residual effect of fentanyl and the rapid elimination of remifentanil.</p><p>The propofol-anaesthetized patients receiving either fentanyl or remifentanil as opioid supplement showed that propofol&#x02013;fentanyl anaesthesia resulted in a higher incidence of PONV and higher requirements of antiemetic drugs compared with propofol-remifentanil group l.[<xref ref-type="bibr" rid="CIT22">22</xref>] The incidence of PONV after administration of general anaesthesia without antiemetic prophylaxis is reported to be in the range of 35&#x02013;60%. However, the reduced incidence of PONV reported in the current study can be attributed to pre-operative use of ondansetron and dexamethasone and this reflects the necessity of the use of prophylactic antiemetic when remifentanil is used.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>We conclude that remifentanil is appropriate for opioid-based anaesthesia in paediatric patients because it provides haemodynamic stability and rapid recovery characteristics with minimal PO side effects. However, attention must be paid for prophylactic antiemetics and adequate post-operative analgesia.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="CIT1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazoit</surname><given-names>JK</given-names></name></person-group><article-title>Pharmacokinetic/pharmacodynamic modeling of anaesthetics in children: Therapeutic implications</article-title><source>Paediatr Drugs</source><year>2006</year><volume>8</volume><fpage>139</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">16774294</pub-id></element-citation></ref><ref id="CIT2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duthie</surname><given-names>DJ</given-names></name></person-group><article-title>Remifentanil and tramadol</article-title><source>Br J Anesth</source><year>1998</year><volume>81</volume><fpage>51</fpage><lpage>7</lpage></element-citation></ref><ref id="CIT3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastronardi</surname><given-names>P</given-names></name><name><surname>Dellacasa</surname><given-names>P</given-names></name></person-group><article-title>Observational study on the use of remifentanil in general anaesthesia. Drug utilization research</article-title><source>Minerva Anestesiol</source><year>2004</year><volume>70</volume><fpage>605</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">15252372</pub-id></element-citation></ref><ref id="CIT4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsui</surname><given-names>BC</given-names></name><name><surname>Wagner</surname><given-names>A</given-names></name><name><surname>Usher</surname><given-names>AG</given-names></name><name><surname>Cave</surname><given-names>DA</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name></person-group><article-title>Combined propofol and remifentanil intravenous anaesthesia for paediatric patients undergoing magnetic resonance imaging</article-title><source>Paediatr Anaesth</source><year>2005</year><volume>15</volume><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">15828991</pub-id></element-citation></ref><ref id="CIT5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>P</given-names></name><name><surname>Finkel</surname><given-names>J</given-names></name><name><surname>Orr</surname><given-names>R</given-names></name><name><surname>Fazi</surname><given-names>L</given-names></name><name><surname>Mulroy</surname><given-names>J</given-names></name><name><surname>Woefel</surname><given-names>S</given-names></name><etal/></person-group><article-title>A randomized, double-blinded study of remifentanil versus fentanyl for tonsillectomy and adenoidectomy surgery in paediatric ambulatory surgical patients</article-title><source>Anesth Analg</source><year>2000</year><volume>90</volume><fpage>863</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">10735790</pub-id></element-citation></ref><ref id="CIT6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>PJ</given-names></name><name><surname>Cladis</surname><given-names>FP</given-names></name></person-group><article-title>The use of ultra-short-acting opioids in paediatric anaesthesia: The role of remifentanil</article-title><source>Clin Pharmacokinet</source><year>2005</year><volume>44</volume><fpage>787</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">16029065</pub-id></element-citation></ref><ref id="CIT7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drover</surname><given-names>DR</given-names></name><name><surname>Litalien</surname><given-names>C</given-names></name><name><surname>Wellis</surname><given-names>V</given-names></name><name><surname>Shafer</surname><given-names>SL</given-names></name><name><surname>Hammer</surname><given-names>GB</given-names></name></person-group><article-title>Determination of the pharmacodynamic interaction of propofol and remifentanil during esophagogastro-duodenoscopy in children</article-title><source>Anesthesiology</source><year>2004</year><volume>100</volume><fpage>1382</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15166555</pub-id></element-citation></ref><ref id="CIT8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manyam</surname><given-names>SC</given-names></name><name><surname>Gupta</surname><given-names>DK</given-names></name><name><surname>Johnson</surname><given-names>KB</given-names></name><name><surname>White</surname><given-names>JL</given-names></name><name><surname>Pace</surname><given-names>NL</given-names></name><name><surname>Westenskow</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Opioid-volatile anaesthetic synergy: A response surface model with remifentanil and sevoflurane as prototypes</article-title><source>Anesthesiology</source><year>2006</year><volume>l105</volume><fpage>267</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">16871060</pub-id></element-citation></ref><ref id="CIT9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poortmans</surname><given-names>G</given-names></name></person-group><article-title>Anaesthesia for children with congenital heart disease undergoing diagnostic and interventional procedures</article-title><source>Curr Opin Anaesthesiol</source><year>2004</year><volume>17</volume><fpage>335</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17021574</pub-id></element-citation></ref><ref id="CIT10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>F</given-names></name><name><surname>Pohl</surname><given-names>F</given-names></name><name><surname>Hollnberger</surname><given-names>H</given-names></name><name><surname>Taeger</surname><given-names>K</given-names></name></person-group><article-title>Impact of the Narcotrend Index on propofol consumption and emergence times during total intravenous anaesthesia with propofol and remifentanil in children: A clinical utility study</article-title><source>Eur J Anaesthesiol</source><year>2005</year><volume>22</volume><fpage>741</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16211731</pub-id></element-citation></ref><ref id="CIT11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitts</surname><given-names>MC</given-names></name><name><surname>Palmore</surname><given-names>MM</given-names></name><name><surname>Salmenpera</surname><given-names>M</given-names></name></person-group><article-title>Hemodynamic effects of intravenous GI 87084B (GI) in patients undergoing elective surgery</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>A101</fpage></element-citation></ref><ref id="CIT12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dershwitz</surname><given-names>M</given-names></name><name><surname>Randel</surname><given-names>G</given-names></name><name><surname>Rosow</surname><given-names>C</given-names></name></person-group><article-title>Initial clinical experience with remifentanil, a new opioid metabolized by esterases</article-title><source>Anesth Analg</source><year>1995</year><volume>81</volume><fpage>619</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">7653833</pub-id></element-citation></ref><ref id="CIT13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffranietz</surname><given-names>L</given-names></name><name><surname>Wolfel</surname><given-names>H</given-names></name><name><surname>Fritz</surname><given-names>H</given-names></name><name><surname>Rudolph</surname><given-names>C</given-names></name></person-group><article-title>Is the combination of remifentanil and propopfol suitable for transsphenoid resection of the hypophysis?</article-title><source>Anaesthesiol Reanim</source><year>2003</year><volume>28</volume><fpage>45</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12756965</pub-id></element-citation></ref><ref id="CIT14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarkkila</surname><given-names>P</given-names></name><name><surname>Viitanen</surname><given-names>H</given-names></name><name><surname>Mennander</surname><given-names>S</given-names></name><name><surname>Annila</surname><given-names>P</given-names></name></person-group><article-title>Comparison of remifentanil versus ketamine for paediatric day case adenoidectomy</article-title><source>Acta Anaesthesiol Belg</source><year>2003</year><volume>54</volume><fpage>217</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">14598618</pub-id></element-citation></ref><ref id="CIT15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batra</surname><given-names>YK</given-names></name><name><surname>Al Qattan</surname><given-names>AR</given-names></name><name><surname>Ali</surname><given-names>SS</given-names></name><name><surname>Qureshi</surname><given-names>MI</given-names></name><name><surname>Kuriakose</surname><given-names>D</given-names></name><name><surname>Migahed</surname><given-names>A</given-names></name></person-group><article-title>Assessment of tracheal intubating conditions in children using remifentanil and propofol without muscle relaxant</article-title><source>Paediatr Anaesth</source><year>2004</year><volume>14</volume><fpage>452</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15153205</pub-id></element-citation></ref><ref id="CIT16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Detriche</surname><given-names>O</given-names></name><name><surname>Berr&#x000e9;</surname><given-names>J</given-names></name><name><surname>Massaut</surname><given-names>J</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group><article-title>The brussels sedation scale: Use of a simple clinical sedation scale can avoid excessive sedation in patients undergoing mechanical ventilation in the intensive care unit</article-title><source>Br J Anaesth</source><year>1999</year><volume>83</volume><fpage>698</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">10690129</pub-id></element-citation></ref><ref id="CIT17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>SI</given-names></name><name><surname>Chung</surname><given-names>F</given-names></name></person-group><article-title>Discharge criteria and complications after ambulatory surgery</article-title><source>Anesth Analg</source><year>1999</year><volume>88</volume><fpage>508</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">10071996</pub-id></element-citation></ref><ref id="CIT18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balakrishnan</surname><given-names>G</given-names></name><name><surname>Raudzens</surname><given-names>P</given-names></name><name><surname>Samra</surname><given-names>SK</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Boening</surname><given-names>JA</given-names></name><name><surname>Bosek</surname><given-names>V</given-names></name><etal/></person-group><article-title>A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions</article-title><source>Anesth Analg</source><year>2000</year><volume>91</volume><fpage>163</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10866905</pub-id></element-citation></ref><ref id="CIT19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samra</surname><given-names>S</given-names></name><name><surname>Dy</surname><given-names>E</given-names></name><name><surname>Welch</surname><given-names>K</given-names></name><name><surname>Lovely</surname><given-names>L</given-names></name><name><surname>Graziano</surname><given-names>G</given-names></name></person-group><article-title>Remifentanil- and fentanyl-based anaesthesia for intraoperative monitoring of somatosensory evoked potentials</article-title><source>Anesth Analg</source><year>2004</year><volume>92</volume><fpage>1510</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11375835</pub-id></element-citation></ref><ref id="CIT20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cicek</surname><given-names>M</given-names></name><name><surname>Koroglu</surname><given-names>A</given-names></name><name><surname>Demirbilek</surname><given-names>S</given-names></name><name><surname>Teksan</surname><given-names>H</given-names></name><name><surname>Ersoy</surname><given-names>MO</given-names></name></person-group><article-title>Comparison of propofol-alfentanil and propofol-remifentanil anaesthesia in percutaneous nephrolithotripsy</article-title><source>Eur J Anaesthesiol</source><year>2005</year><volume>22</volume><fpage>683</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16163915</pub-id></element-citation></ref><ref id="CIT21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glaisyer</surname><given-names>HR</given-names></name></person-group><article-title>Sury MR. Recovery after anaesthesia for short paediatric oncology procedures: Propofol and remifentanil compared with propofol, nitrous oxide, and sevoflurane</article-title><source>Anesth Analg</source><year>2005</year><volume>100</volume><fpage>959</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15781506</pub-id></element-citation></ref><ref id="CIT22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rama-Maceiras</surname><given-names>P</given-names></name><name><surname>Ferreira</surname><given-names>TA</given-names></name><name><surname>Molins</surname><given-names>N</given-names></name><name><surname>Sanduende</surname><given-names>Y</given-names></name><name><surname>Bautista</surname><given-names>AP</given-names></name><name><surname>Rey</surname><given-names>T</given-names></name></person-group><article-title>Less postoperative nausea and vomiting after propofol + remifentanil versus propofol + fentanyl anaesthesia during plastic surgery</article-title><source>Acta Anaesthesiol Scand</source><year>2005</year><volume>49</volume><fpage>305</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15752393</pub-id></element-citation></ref></ref-list></back></article>